• Home  /
  • Healthcare   /
  • Alton Gregg H decreases stake in Gilead Sciences, Inc. (NASDAQ:GILD) with selling 50000 shares worth of $3950000

Alton Gregg H decreases stake in Gilead Sciences, Inc. (NASDAQ:GILD) with selling 50000 shares worth of $3950000

Gilead Sciences, Inc. (NASDAQ:GILD) closed the trading with positive move of +0.05% and finish the day at $83.75 which had been above its previous day’s closing of $83.71. The firm has price to sales ratio of 3.84 and its price to book per share was 4.82. The stock is trading higher its 50-day moving averages of 74.38 and above 200-day moving averages of 69.29. The shares registered one year high of $84.13 and one year low was seen at $63.76.

Shares of the company registered a buying and selling volume of 14.31 million shares higher than its 3-months average volume of 9.77 million shares and traded in range of $82.25 to $84.10.

Recent Insider Selling Activity:

Currently the Insiders own 0.30% of Gilead Sciences, Inc. shares. Institutional Investors own 77.40% of company’s shares. During last three month period, the net percent change held by Institutional Investors has seen a change of 0.55%. During last six month period, the net percent change kept by insiders has seen a change of -11.34%.

In the company’s insider trading activities, Alton Gregg H; EVP Comm&Acs ALA, Corp&Med Aff of Gilead Sciences, Inc. sold 50000 shares worth of $3950000 in a transaction on 30 Aug 2017. In this transaction, these shares were sold at value of $79 per share, according to the information disclosed by the Securities and Exchange Commission in a Form 4 filing on 01 Sep 2017.

Alton Gregg H; EVP Comm&Acs ALA, Corp&Med Aff of Gilead Sciences, Inc. also sold 15000 shares worth of $1138190 in a transaction dated on 01 Aug 2017. Shares were sold at the average price of 75.88 per share, according to SEC Form 4 filing submitted on 03 Aug 2017.

In other transaction, MARTIN JOHN C (Executive Chairman) sold 73333 shares on 01 Aug 2017 worth of $5562777. In this Insider Trading activity, shares were sold with per share cost of $75.86.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a comment